<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">infectpataog</journal-id><journal-title-group><journal-title xml:lang="ru">Дальневосточный журнал инфекционной патологии</journal-title><trans-title-group xml:lang="en"><trans-title>Far Eastern Journal of Infectious Pathology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-2899</issn><publisher><publisher-name>ФБУН Хабаровский НИИ эпидемиологии и микробиологии Роспотребнадзора</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">infectpataog-411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>СИСТЕМА АПОПТОЗА FAS/APO-1/CD95 И ЕЕ РОЛЬ В ПАТОГЕНЕЗЕ ВИЧ-ИНФЕКЦИИ И ПАРЕНТЕРАЛЬНЫХ ВИРУСНЫХ ГЕПАТИТОВ (ОБЗОР ЛИТЕРАТУРЫ)</article-title><trans-title-group xml:lang="en"><trans-title>FAS/APO-1/CD95 INDUCED APOPTOSIS AND IT’S ROLE IN PATHOGENESIS OF HIV-INFECTION AND PARENTERAL VIRAL HEPATITIS (LITERATURE REVIEW)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Базыкина</surname><given-names>Е. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazykina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Базыкина Елена Анатольевна – научный сотрудник лаборатории эпидемиологии и профилактики ВИЧ-инфекции и вирусных гепатитов</p><p>Хабаровск</p></bio><bio xml:lang="en"><p>Khabarovsk</p></bio><email xlink:type="simple">adm@hniiem.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Троценко</surname><given-names>О. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Trotsenko</surname><given-names>О. Е.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хабаровск</p></bio><bio xml:lang="en"><p>Khabarovsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН Хабаровский НИИ эпидемиологии и микробиологии Роспотребнадзора</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FBIS Khabarovsk research institute of epidemiology and microbiology of the Federal service for surveillance on consumers rights protection and human wellbeing (Rospotrebnadzor)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2025</year></pub-date><volume>0</volume><issue>38</issue><fpage>13</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Базыкина Е.A., Троценко О.Е., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Базыкина Е.A., Троценко О.Е.</copyright-holder><copyright-holder xml:lang="en">Bazykina E.A., Trotsenko О.Е.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://infectpataog.elpub.ru/jour/article/view/411">https://infectpataog.elpub.ru/jour/article/view/411</self-uri><abstract><p>Обзор литературы посвящен изучению влияния ВИЧ, вирусов парентеральных гепатитов В, С (ВГВ, ВГС) и человеческого пегивируса 1 типа (human pegivirus-1 – HPgV-1), ранее известного как GBV-C или вирусный гепатит G, на систему апоптоза. При инфицировании человека ВИЧ, ВГВ и ВГС происходит дисрегуляция процессов апоптоза, что считается одним из звеньев патогенеза как состояний, спровоцированных указанными возбудителями, так и различных неопластических процессов. Обсуждается влияние дисрегуляции системы апоптоза на развитие поражения печени и возникновение гепатоцеллюлярной карциномы, вызванной ВГС. В отличие от других вирусов HPgV-1 обладает благоприятным влиянием на течение ВИЧ-инфекции, что связано с многими процессами, происходящими в организме инфицированного пациента, например, с изменением синтеза хемокинов группы RANTES, влиянием антител к белку E2 HPgV-1 на ход инфекционного процесса. Особый упор сделан на изучении влияния Fas-индуцированного пути апоптоза, являющегося основным патогенетическим звеном ВИЧ-инфекции, ведущим к лавинообразной гибели CD4+ лимфоцитов. Обсуждается влияние белков ВИЧ (gp 120, Vpr, Nef) на прогрессию заболевания. Углубленное изучение механизмов, лежащих в основе нарушения запрограммированной гибели клеток, может привести к созданию новых подходов в диагностике и лечении различных патологических процессов, в частности, ВИЧ-инфекции и вирусных гепатитов.</p></abstract><trans-abstract xml:lang="en"><p>The current literature review highlights the issues concerning influence of HIV and hepatitis B and C viruses (HBV, HCV), human pegivirus type 1 (HPgV-1) previously known as GBV-C or hepatitis G virus on programmed cell death. Different infections such as HIV, HBV and HCV can provoke dysregulation in apoptosis, which is known to play a part in their pathogenesis as well as induce neoplastic processes in human organism. The article discusses influence of disruption of apoptosis on liver injury and hepatic hepatocellular carcinoma formation specifically induced by HCV. Unlike other viruses, HPgV-1 infection process can favor HIV-infection course. For example, it is known that HPgV-1 alters HIV-infection state due to induction of RANTES chemokines and HPgV-1 viral E2 glycoprotein secretion. Particular emphasis was drawn on the Fas-induced apoptosis that is a fundamental part of HIV pathogenesis and triggers massive death of CD4+ lymphocytes. Influence of HIV proteins (gp 120, Vpr, Nef) on progression of the disease was also discussed. A thorough study of mechanisms that induce disruption of programmed cell death can lead to invention of innovative approaches of diagnosis and treatment of variety of pathologic processes including HIVinfection and viral hepatitis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ВИЧ-инфекция</kwd><kwd>парентеральные вирусные гепатиты</kwd><kwd>апоптоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>HIV infection</kwd><kwd>viral hepatitis</kwd><kwd>apoptosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бобкова МР. «Иммунитет и ВИЧ-инфекция». - М.: Олимпия Пресс, 2006. - 240 с.</mixed-citation><mixed-citation xml:lang="en">Бобкова МР. «Иммунитет и ВИЧ-инфекция». - М.: Олимпия Пресс, 2006. - 240 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Жаворонок СВ, Москалева НВ, Тумаш ОЛ, Барышников АЮ. Перспективы килинико-лабораторного использования растворимой формы антигена CD95 // Наука и инновации. – 2014. – № 3, Vol. 133. - P. 67-72.</mixed-citation><mixed-citation xml:lang="en">Жаворонок СВ, Москалева НВ, Тумаш ОЛ, Барышников АЮ. Перспективы килинико-лабораторного использования растворимой формы антигена CD95 // Наука и инновации. – 2014. – № 3, Vol. 133. - P. 67-72.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Лаврик И, Краммер П. Решение «жизнь-или-смерть» в системе CD95: основные про- и антиапоптозные модуляторы // ACTA NATURAE. – 2009. –№ l. - Р.80-83</mixed-citation><mixed-citation xml:lang="en">Лаврик И, Краммер П. Решение «жизнь-или-смерть» в системе CD95: основные про- и антиапоптозные модуляторы // ACTA NATURAE. – 2009. –№ l. - Р.80-83</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Москалева НВ. Растворимая форма Fas/Apo-1-антигена в периферической крови при ВИЧинфекции / Н. В. Москалева, С. В. Жаворонок, О. Л. Тумаш // Актуальные вопросы инфекционной патологии: 6-й съезд инфекционистов Республики Беларусь, Витебск, 29-30 мая 2014 г. - Витебск: ВГМУ, 2014. - С. 129-130.</mixed-citation><mixed-citation xml:lang="en">Москалева НВ. Растворимая форма Fas/Apo-1-антигена в периферической крови при ВИЧинфекции / Н. В. Москалева, С. В. Жаворонок, О. Л. Тумаш // Актуальные вопросы инфекционной патологии: 6-й съезд инфекционистов Республики Беларусь, Витебск, 29-30 мая 2014 г. - Витебск: ВГМУ, 2014. - С. 129-130.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Arokium H, Kamata M, Chen I. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances Fas-induced apoptosis in human T cells // J Virol. – 2009. – № 83. Vol. 21. – P. 11283-11297. doi: 10.1128/JVI.00756-09;</mixed-citation><mixed-citation xml:lang="en">Arokium H, Kamata M, Chen I. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances Fas-induced apoptosis in human T cells // J Virol. – 2009. – № 83. Vol. 21. – P. 11283-11297. doi: 10.1128/JVI.00756-09;</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Balasubramanian A, Koziel M, Groopman JE, Ganju RK. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV // Clin Infect Dis. Suppl 1– 2005. – № 41. – P. 32–S37. doi:10.1086/429493</mixed-citation><mixed-citation xml:lang="en">Balasubramanian A, Koziel M, Groopman JE, Ganju RK. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV // Clin Infect Dis. Suppl 1– 2005. – № 41. – P. 32–S37. doi:10.1086/429493</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Balestrieri E, Grelli S, Matteucci C, et al. Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy // J Med Virol. – 2007. – № 79, Vol. 2. – P. 111-117. doi: 10.1002/jmv.20768.</mixed-citation><mixed-citation xml:lang="en">Balestrieri E, Grelli S, Matteucci C, et al. Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy // J Med Virol. – 2007. – № 79, Vol. 2. – P. 111-117. doi: 10.1002/jmv.20768.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chavan SJ, Tamma SL, Kaplan M, et al. Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy // Clin Immunol. – 1999. – № 93, Vol. 1. – P. 24-33. doi: 10.1006/clim.1999.4770.</mixed-citation><mixed-citation xml:lang="en">Chavan SJ, Tamma SL, Kaplan M, et al. Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy // Clin Immunol. – 1999. – № 93, Vol. 1. – P. 24-33. doi: 10.1006/clim.1999.4770.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dockrell DH, Badley AD, Algeciras-Schimnich A, et al. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number // AIDS Res Hum Retroviruses. – 1999. – № 15, Vol 17. – p. 1509-1518. doi: 10.1089/088922299309793.</mixed-citation><mixed-citation xml:lang="en">Dockrell DH, Badley AD, Algeciras-Schimnich A, et al. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number // AIDS Res Hum Retroviruses. – 1999. – № 15, Vol 17. – p. 1509-1518. doi: 10.1089/088922299309793.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ehrhard S, Wernli M, Kaufmann G, et al. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals // Infection. – 2008. – №36, Vol. 2. – P. 120- 129. doi: 10.1007/s15010-008-7368-9.</mixed-citation><mixed-citation xml:lang="en">Ehrhard S, Wernli M, Kaufmann G, et al. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals // Infection. – 2008. – №36, Vol. 2. – P. 120- 129. doi: 10.1007/s15010-008-7368-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Feuth T, Van Baarle D, Hoepelman AI, et al. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity // Apoptosis. – 2014. – № 19, Vol. 7. – P. 1128–1135. doi:10.1007/s10495-014-0992-1</mixed-citation><mixed-citation xml:lang="en">Feuth T, Van Baarle D, Hoepelman AI, et al. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity // Apoptosis. – 2014. – № 19, Vol. 7. – P. 1128–1135. doi:10.1007/s10495-014-0992-1</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fukumori T, Akari H, Yoshida A, et al. Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr // Microbes Infect. – 2000. –№ 2, Vol 9. – P. 1011-1017. doi: 10.1016/s1286-4579(00)01255-7.</mixed-citation><mixed-citation xml:lang="en">Fukumori T, Akari H, Yoshida A, et al. Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr // Microbes Infect. – 2000. –№ 2, Vol 9. – P. 1011-1017. doi: 10.1016/s1286-4579(00)01255-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Grelli S, Campagna S, Lichtner M, et al. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy // AIDS. – 2000. - № 14, Vol. 8. – P. 939-949. doi: 10.1097/00002030-200005260-00005.</mixed-citation><mixed-citation xml:lang="en">Grelli S, Campagna S, Lichtner M, et al. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy // AIDS. – 2000. - № 14, Vol. 8. – P. 939-949. doi: 10.1097/00002030-200005260-00005.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hammam O, Mahmoud O, Zahran M et al. The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma // Hepatitis Monthly. – 2012. – № 12, Vol. 11: e6132. doi:10.5812/hepatmon.6132</mixed-citation><mixed-citation xml:lang="en">Hammam O, Mahmoud O, Zahran M et al. The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma // Hepatitis Monthly. – 2012. – № 12, Vol. 11: e6132. doi:10.5812/hepatmon.6132</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Holm GH, Gabuzda D. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions // J Virol. – 2005. – № 79, Vol, 10. – P. 6299-6311. doi: 10.1128/JVI.79.10.6299-6311.2005.</mixed-citation><mixed-citation xml:lang="en">Holm GH, Gabuzda D. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions // J Virol. – 2005. – № 79, Vol, 10. – P. 6299-6311. doi: 10.1128/JVI.79.10.6299-6311.2005.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ikomey GM, Okomo-Assoumou MC, Atashili J, et al. Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon // BMC Res Notes. – 2012. – №5. – Р. 322. doi: 10.1186/1756-0500-5-322.</mixed-citation><mixed-citation xml:lang="en">Ikomey GM, Okomo-Assoumou MC, Atashili J, et al. Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon // BMC Res Notes. – 2012. – №5. – Р. 322. doi: 10.1186/1756-0500-5-322.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Li-Weber M, Weigand MA, Giaisi M, et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death // J Clin Invest. 2002. – № 110, Vol. 5. – P. 681-690. doi: 10.1172/JCI15073.</mixed-citation><mixed-citation xml:lang="en">Li-Weber M, Weigand MA, Giaisi M, et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death // J Clin Invest. 2002. – № 110, Vol. 5. – P. 681-690. doi: 10.1172/JCI15073.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Macias J, Japón MA, Sáez C, et al. Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection // J Infect Dis. – 2005. – № 192, Vol 9. – P. 1566-1576. doi: 10.1086/491736.</mixed-citation><mixed-citation xml:lang="en">Macias J, Japón MA, Sáez C, et al. Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection // J Infect Dis. – 2005. – № 192, Vol 9. – P. 1566-1576. doi: 10.1086/491736.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Matarrese P, Gambardella L, Cassone A, et al. Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors // J Immunol. - 2003. – № 170, Vol. 12. – P. 6006-6015. doi: 10.4049/jimmunol.170.12.6006.</mixed-citation><mixed-citation xml:lang="en">Matarrese P, Gambardella L, Cassone A, et al. Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors // J Immunol. - 2003. – № 170, Vol. 12. – P. 6006-6015. doi: 10.4049/jimmunol.170.12.6006.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Moenkemeyer M, Schmidt RE, Wedemeyer H, et al. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients // J Med Virol. – 2008. – № 80, Vol. 11. – P. 1933–1940. doi:10.1002/jmv.21305</mixed-citation><mixed-citation xml:lang="en">Moenkemeyer M, Schmidt RE, Wedemeyer H, et al. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients // J Med Virol. – 2008. – № 80, Vol. 11. – P. 1933–1940. doi:10.1002/jmv.21305</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Moretti S, Alesse E, Marcellini S, et al. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis // Immunopharmacol Immunotoxicol. – 1999. – № 21, Vol. 4. – P. 645-665. doi: 10.3109/08923979909007132.</mixed-citation><mixed-citation xml:lang="en">Moretti S, Alesse E, Marcellini S, et al. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis // Immunopharmacol Immunotoxicol. – 1999. – № 21, Vol. 4. – P. 645-665. doi: 10.3109/08923979909007132.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Munshi N, Balasubramanian A, Koziel M, et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism // J Infect Dis. – 2003. – № 188, Vol. 8. – P. 1192–1204. doi:10.1086/378643</mixed-citation><mixed-citation xml:lang="en">Munshi N, Balasubramanian A, Koziel M, et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism // J Infect Dis. – 2003. – № 188, Vol. 8. – P. 1192–1204. doi:10.1086/378643</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Nair MPN, Mahajan S, Hou J, et al. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells // Cell Mol Biol (Noisy-le-grand). – 2000. – № 46, Vol. 7. – P. 1227-1238.</mixed-citation><mixed-citation xml:lang="en">Nair MPN, Mahajan S, Hou J, et al. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells // Cell Mol Biol (Noisy-le-grand). – 2000. – № 46, Vol. 7. – P. 1227-1238.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">O'Connell J, Houston A, Bennett MW, et al. Immune privilege or inflammation Insights into the Fas ligand enigma // Nat. Med. – 2001. – № 7. – Р. 271–274.</mixed-citation><mixed-citation xml:lang="en">O'Connell J, Houston A, Bennett MW, et al. Immune privilege or inflammation Insights into the Fas ligand enigma // Nat. Med. – 2001. – № 7. – Р. 271–274.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pan T, Wu S, He X, et al. Necroptosis takes place in human immunodeficiency virus type-1 (HIV1)-infected CD4+ T lymphocytes // PLoS One. – 2014. – № 9, Vol. 4: e93944. doi: 10.1371/journal.pone.0093944.</mixed-citation><mixed-citation xml:lang="en">Pan T, Wu S, He X, et al. Necroptosis takes place in human immunodeficiency virus type-1 (HIV1)-infected CD4+ T lymphocytes // PLoS One. – 2014. – № 9, Vol. 4: e93944. doi: 10.1371/journal.pone.0093944.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Poonia B., Pauza CD, Salvato MS. Role of the Fas/FasL pathway in HIV or SIV disease // Retrovirology. – 2009. – № 6. – Р. 91. doi:10.1186/1742-4690-6-91.</mixed-citation><mixed-citation xml:lang="en">Poonia B., Pauza CD, Salvato MS. Role of the Fas/FasL pathway in HIV or SIV disease // Retrovirology. – 2009. – № 6. – Р. 91. doi:10.1186/1742-4690-6-91.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Purevjav E, Nelson DP, Varela JJ, et al. Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy // Cardiovasc Toxicol. – 2007. – № 7, Vol. 4. – P. 255-263. doi: 10.1007/s12012-007-9004-9.</mixed-citation><mixed-citation xml:lang="en">Purevjav E, Nelson DP, Varela JJ, et al. Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy // Cardiovasc Toxicol. – 2007. – № 7, Vol. 4. – P. 255-263. doi: 10.1007/s12012-007-9004-9.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Raghuraman S, Abraham P, Daniel HD, et al. Characterization of soluble FAS, FAS ligand and tumor necrosis factor-alpha in patients with chronic HCV infection // J Clin Virol. – 2005. – № 34, Vol 1. – P. 63–70. doi:10.1016/j.jcv.2005.01.009</mixed-citation><mixed-citation xml:lang="en">Raghuraman S, Abraham P, Daniel HD, et al. Characterization of soluble FAS, FAS ligand and tumor necrosis factor-alpha in patients with chronic HCV infection // J Clin Virol. – 2005. – № 34, Vol 1. – P. 63–70. doi:10.1016/j.jcv.2005.01.009</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Restifo NP. Countering the 'counterattack' hypothesis // Nat. Med. – 2001. –№ 7, Vol 3. - P. 259 doi: 10.1038/85357.</mixed-citation><mixed-citation xml:lang="en">Restifo NP. Countering the 'counterattack' hypothesis // Nat. Med. – 2001. –№ 7, Vol 3. - P. 259 doi: 10.1038/85357.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Roger PM, Breittmayer JP, Durant J, et al; Groupe d'Etudes Niçois Polyvalent en Infectiologie. Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation // J Infect Dis. – 2002. – № 185, Vol. 4. – P. 463-470. doi: 10.1086/338573.</mixed-citation><mixed-citation xml:lang="en">Roger PM, Breittmayer JP, Durant J, et al; Groupe d'Etudes Niçois Polyvalent en Infectiologie. Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation // J Infect Dis. – 2002. – № 185, Vol. 4. – P. 463-470. doi: 10.1086/338573.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Schwarze-Zander C, Blackard JT, Rockstroh JK. Role of GB virus C in modulating HIV disease // Expert Rev Anti Infect Ther. – 2012. – № 10, Vol. 5. - P. 563–572. doi:10.1586/eri.12.37</mixed-citation><mixed-citation xml:lang="en">Schwarze-Zander C, Blackard JT, Rockstroh JK. Role of GB virus C in modulating HIV disease // Expert Rev Anti Infect Ther. – 2012. – № 10, Vol. 5. - P. 563–572. doi:10.1586/eri.12.37</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sevilya Z, Chorin E, Gal-Garber O, et al. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef // Front Immunol. – 2018. – № 9. – P.2068. doi: 10.3389/fimmu.2018.02068. PMID: 30254642;</mixed-citation><mixed-citation xml:lang="en">Sevilya Z, Chorin E, Gal-Garber O, et al. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef // Front Immunol. – 2018. – № 9. – P.2068. doi: 10.3389/fimmu.2018.02068. PMID: 30254642;</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Shata MTM, Abdel-Hameed EA, Rouster SD, et al. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Version 2 // Pathog Immun. – 2019. – № 4, Vol. 1. – P. 39-65. doi: 10.20411/pai.v4i1.267.</mixed-citation><mixed-citation xml:lang="en">Shata MTM, Abdel-Hameed EA, Rouster SD, et al. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Version 2 // Pathog Immun. – 2019. – № 4, Vol. 1. – P. 39-65. doi: 10.20411/pai.v4i1.267.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease // Proc Natl Acad Sci USA. – 1997. – № 94, Vol. 11. – P. 5860-5865. doi: 10.1073/pnas.94.11.5860.</mixed-citation><mixed-citation xml:lang="en">Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease // Proc Natl Acad Sci USA. – 1997. – № 94, Vol. 11. – P. 5860-5865. doi: 10.1073/pnas.94.11.5860.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Silvestris F, Cafforio P, Frassanito MA, et al. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis // AIDS. – 1996.– №10, Vol. 2. – P. 131-141. doi: 10.1097/00002030-199602000-00002.</mixed-citation><mixed-citation xml:lang="en">Silvestris F, Cafforio P, Frassanito MA, et al. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis // AIDS. – 1996.– №10, Vol. 2. – P. 131-141. doi: 10.1097/00002030-199602000-00002.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system // Immunity. j.immuni. – 2009. – № 30, Vol. 2. – P. 180-192. doi:10.1016/2009.01.001.</mixed-citation><mixed-citation xml:lang="en">Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system // Immunity. j.immuni. – 2009. – № 30, Vol. 2. – P. 180-192. doi:10.1016/2009.01.001.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Wang XZ, Chen XC, Chen YX. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system // World J. Gastroenterol. 2003. – № 9, Vol. 12. – P. 2671–2675. doi: 10.3748/wjg.v9.i12.2671.</mixed-citation><mixed-citation xml:lang="en">Wang XZ, Chen XC, Chen YX. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system // World J. Gastroenterol. 2003. – № 9, Vol. 12. – P. 2671–2675. doi: 10.3748/wjg.v9.i12.2671.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wu NP, Li D, Bader A, et al. Effect of HIV-1 infection on apoptosis of CD4+ T lymphocytes mediated by Fas // Zhejiang Da Xue Xue Bao Yi Xue Ban. – 2003. –№ 32, Vol 2. – P. 90-93.</mixed-citation><mixed-citation xml:lang="en">Wu NP, Li D, Bader A, et al. Effect of HIV-1 infection on apoptosis of CD4+ T lymphocytes mediated by Fas // Zhejiang Da Xue Xue Bao Yi Xue Ban. – 2003. –№ 32, Vol 2. – P. 90-93.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Xu XN, Laffert B, Screaton GR, et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain // J Exp Med. 1999. – № 189, Vol. 9. – P.1489-1496. doi: 10.1084/jem.189.9.1489.</mixed-citation><mixed-citation xml:lang="en">Xu XN, Laffert B, Screaton GR, et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain // J Exp Med. 1999. – № 189, Vol. 9. – P.1489-1496. doi: 10.1084/jem.189.9.1489.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
